Old Web
English
Sign In
Acemap
>
Paper
>
PCV26 ALL-Cause and Bleeding Costs of Patients Initiating P2Y12 Inhibitors, Fxa Inhibitors, and Dabigatran
PCV26 ALL-Cause and Bleeding Costs of Patients Initiating P2Y12 Inhibitors, Fxa Inhibitors, and Dabigatran
2021
A. Kong
J. Lee
K. Evans
C. Morrow
J. Erickson
Deepak L. Bhatt
Keywords:
Intensive care medicine
all cause mortality
Medicine
Dabigatran
P2Y12
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]